Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
BJU International|May 31, 2024
Quality-of-life outcomes of the ROBOtic-assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trialMarie Angela Sidoti Abate, Hanna Saskia Menold, Manuel Neuberger, et al.
European Urology Oncology|August 5, 2023
Peritoneal Flap for Lymphocele Prophylaxis Following Robotic-assisted Radical Prostatectomy with Lymph Node Dissection: The Randomised Controlled Phase 3 PELYCAN TrialManuel Neuberger, Karl-Friedrich Kowalewski, Valentin Simon, et al.
Anticancer Research|December 30, 2022
Integrin Expression in Localized Prostate Cancer: A TCGA and MSKCC Cohort-based Exploratory In Silico AnalysisManuel Neuberger, Lisa Frey, Katja Nitschke, et al.
Urologia Internationalis|December 8, 2022
Prospective, Randomized Comparative Evaluation of a Novel Hands-On Endourology Training CurriculumFrank Waldbillig, Lennard von Rohr, Malin Nientiedt, et al.
Minerva Urology and Nephrology|March 11, 2022
Artificial intelligence to predict oncological outcome directly from hematoxylin and eosin-stained slides in urologyFrederik Wessels, Sara Kuntz, Eva Krieghoff-Henning, et al.
BMJ Open|November 4, 2021
ROBOCOP II (ROBOtic assisted versus conventional open partial nephrectomy) randomised, controlled feasibility trial: clinical trial protocolKarl-Friedrich Kowalewski, Marie Angela Sidoti Abate, Manuel Neuberger, et al.
European Urology Focus|February 27, 2026
Two-year Follow-up for Oncological, Functional, and Quality-of-Life Outcomes in the Randomized ROBOCOP II Trial of Robot-assisted Versus Conventional Open Partial NephrectomyCaelán Max Haney-Aubert, Luise Gottstein, Marie Angela Sidoti Abate, et al.
Urologic Oncology|June 17, 2021
High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancerKatja Nitschke, Thomas S Worst, Sophie Madeleine von Rhade, et al.
International Journal of Surgery Protocols|December 4, 2023
Framework for a living systematic review and meta-analysis for the surgical treatment of bladder cancer: introducing EVIglance to urologyVictoria L S Wieland, Daniel Uysal, Pascal Probst, et al.
Iscience|August 9, 2023
Reinvestigating the clinical relevance of the m6A writer METTL3 in urothelial carcinoma of the bladderJonas Koch, Manuel Neuberger, Martina Schmidt-Dengler, et al.
Pageof 4